Resources

PowerPoint presentation from the webinar, covering info on Australian National Aged Care Classification (AN-ACC) and care minutes, Quarterly Financial Reporting, Basic Daily Fee, eNRMC transitional arrangement, and updates from Services Australia.

PowerPoint presentation on latest information from Australian National Aged Care Classification (AN-ACC), Quarterly Reporting Requirements, Monthly Care Statements and an update from Services Australia.

This summary report outlines the development and design of Star Ratings for residential aged care.

Frequently asked questions about Star Ratings for residential aged care providers.

The Star Ratings Provider Manual contains detailed information about Star Ratings design, calculation and reporting requirements.

Frequently asked questions about Star Ratings for older Australians.

Frequently asked questions about Star Ratings for residential aged care providers.

Information about Star Ratings for older Australians.

This document summarises the discussion and outcomes of the second Roadmap Implementation Governance Group (RIGG) meeting held on 16 March 2022.

This document summarises the discussion and outcomes of the second Roadmap Implementation Governance Group (RIGG) meeting held on 16 March 2022.

This guide explains to team leaders and staff members how to use the My Aged Care service and support portal.

This form is for submitting Disability Support for Older Australians (DSOA) client information.

A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program (LSDP).

A collection of resources for health professionals to help people with hereditary tyrosinaemia type 1 access nitisinone (Orfadin® and Nityr™) under the Life Saving Drugs Program.

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This MPS VI review considered galsulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This MPS VI review considered galsulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This Quick Reference Guide is a step-by-step guide for Organisation Administrators to upload their missing CHSP clients’ data collection template into the My Aged Care Provider Portal and manually add services for each client.

Fact sheets and other health, aged care and sport information from the October 2022–23 Budget.

Key resources relating to in-home aged care

Help keep our mob from getting really sick by knowing these eight truths about Japanese Encephalitis Virus, or JEV.